Literature DB >> 8203727

Antibody-antigen binding constants determined in solution-phase with the threshold membrane-capture system: binding constants for anti-fluorescein, anti-saxitoxin, and anti-ricin antibodies.

K Dill1, M Lin, C Poteras, C Fraser, D G Hafeman, J C Owicki, J D Olson.   

Abstract

Affinities of various monoclonal and polyclonal antibodies for fluorescein-containing antigens, saxitoxin and ricin, were determined by using a light addressable potentiometric sensor-based system (Threshold). The dissociation constants, determined from Scatchard plots, ranged from 2 x 10(-7) to approximately 3 x 10(-12) M. Dissociation constants for fluorescein and saxitoxin were compared with values determined by independent means. This technique was found to be quick, simple, reproducible, and accurate.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8203727     DOI: 10.1006/abio.1994.1093

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  6 in total

1.  Chemomechanical mapping of ligand-receptor binding kinetics on cells.

Authors:  Sunyoung Lee; Jelena Mandic; Krystyn J Van Vliet
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

2.  Detection of human asialo-alpha(1)-acid glycoprotein using a heterosandwich immunoassay in conjunction with the light addressable potentiometric sensor.

Authors:  K Dill; D W Bearden
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

3.  Picogram detection levels of asialofetuin via the carbohydrate moieties using the light addressable potentiometric sensor.

Authors:  K Dill; J D Olson
Journal:  Glycoconj J       Date:  1995-10       Impact factor: 2.916

Review 4.  Promising Therapeutic Strategies for Colorectal Cancer Treatment Based on Nanomaterials.

Authors:  Natalia Krasteva; Milena Georgieva
Journal:  Pharmaceutics       Date:  2022-06-07       Impact factor: 6.525

5.  Universal antibody conjugation to nanoparticles using the Fcγ receptor I (FcγRI): quantitative profiling of membrane biomarkers.

Authors:  Chloe Kim; Justin F Galloway; Kwan Hyi Lee; Peter C Searson
Journal:  Bioconjug Chem       Date:  2014-10-01       Impact factor: 4.774

Review 6.  Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments.

Authors:  Charlene M Dawidczyk; Luisa M Russell; Peter C Searson
Journal:  Front Chem       Date:  2014-08-25       Impact factor: 5.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.